Summary by Moomoo AI
On February 13, 2024, Matsuda Masaru, associated with Arcutis Biotherapeutics, Inc. [ARQT], engaged in multiple transactions involving the acquisition of the company's common stock. The transactions, all classified under the code 'A' indicating grants, awards, or other acquisitions, resulted in a total of 119,550 shares being added to Masaru's direct holdings. The first transaction added 74,000 shares, the second 17,650 shares, and the third 27,900 shares. Following these acquisitions, Masaru's beneficial ownership of Arcutis Biotherapeutics' common stock increased to 194,184 shares. The transactions reflect a positive action status, with the shares being directly held by Masaru.